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Abstract
Background: Cognitive decline is frequently observed in elderly patients after major surgery. The pathophysiology
of postoperative cognitive dysfunction (POCD) remains unclear. The aim of our investigation is to identify potential
associations between brain volume change and POCD in elderly patients undergoing major surgery.
Methods: This is a prospective observational cohort study approved by the regional ethics board. We intend to
compare specific brain volumes (hippocampus, lateral ventricle, total grey matter volume, regional cortical thickness)
on magnetic resonance imaging and cognitive functions determined by a neuropsychological assessment battery in
70 study participants aged ≥65 years before and 3 and 12 months after major noncardiac surgery. Thirty volunteers will
be included as matched nonsurgical controls. The primary endpoint of the study is the change in hippocampal volume
over time in patients with and without POCD. The secondary endpoint is the correlation between the change in cerebral
volume and cognitive function. We will follow the STROBE guidelines for reporting the results of observational studies.
Discussion: We hypothesize that surgery under general anesthesia is associated with a loss of cerebral grey matter, and
that the degree of postoperative cognitive dysfunction correlates with the extent of atrophy in areas of the brain that are
relevant for cognitive functions. The validation of reproducible anatomical biomarkers, such as the specific brain volumes
examined in our cohort, may serve to evaluate the effect of preventive strategies and treatment interventions for POCD in
follow-up studies.
Trial registration: Clinicaltrials.gov NCT02045004. Registered 22 January 2014. Kofam.ch SNCTP000001751. Registered 21
April 2016 (retrospectively registered).
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Background
Anesthesia care for patients in their seventies or eighties
has an ever-growing presence in clinical practice given
the demographic development in many industrialized
countries. Variable degrees of cognitive decline are fre-
quently observed after major surgery in elderly patients and
have been defined as postoperative cognitive dysfunction
(POCD) [1]. Clinical studies have reported an incidence of
POCD of up to 41% in surgical patients older than 60 years
(Table 1) [2]. In many patients, this is a transient problem.
But in some patients, cognitive deficits are long-term or
permanent [1, 2]. POCD may also develop in younger
patients [3] and after minor surgery [4]. The occurrence of
POCD is associated with increased mortality and important
socioeconomic consequences [5].
The potential association between exposure to
anesthesia and the development of dementia in elderly
patients remains a controversial topic [6, 7]. So far, a
direct association between surgery and long-term cogni-
tive decline has not been established [8]. The patho-
physiology of POCD is poorly understood, and no
preventive strategy or treatment has been described so
far [9]. A retrospective analysis of cohort data suggests
that surgery may be associated with a decrease in brain
volume [10]; however, no analysis of a potential link
between cerebral atrophy and cognitive functions was
made. We would like to reproduce and verify these re-
sults and investigate a possible relationship with the
postoperative cognitive performance in surgical patients.
The principal objective of this observational cohort
study is to prospectively test the hypothesis whether
major noncardiac surgery under sevoflurane-based
general anesthesia is associated with a loss of cerebral
grey matter in elderly patients. We also hypothesize that
the degree of POCD correlates with the loss of grey
matter in brain areas relevant for cognitive functions.
Methods
Study design and setting
This prospective, observational cohort study is being
conducted at the University Hospital Basel, Switzerland.
Study recruitment commenced in July 2015 and is
expected to last for 36 months. The regional ethics com-
mittee (EC) approved the study prior to participant in-
clusion (Ethikkommission Nordwestschweiz, protocol:
EKNZ 2014–155, 1 August 2014). The study was
registered on clinicaltrials.gov (NCT02045004) on 22
January 2014 and on Kofam.ch (SNCTP000001751)
on 21 April 2016.
Study population
Two groups of study participants will be investigated in
this prospective cohort study. Seventy patients aged
≥65 years undergoing major surgical procedures will be
recruited for this study (Group 1). Thirty volunteers
aged ≥65 years will be recruited as matched nonsurgical
controls (Group 2).
Recruitment and informed consent
Study participants in the surgical group (Group 1)
will be recruited as patients of the University Hospital
Basel, Switzerland. Eligible patients are identified by
screening the daily list of visits in the preoperative
anesthesia clinic. They are either contacted personally
on the same day, or by mail in a letter including
participant information and a consent form. A follow-
up phone call by an investigator will provide further
information about relevant details of the study. Study
participants in the nonsurgical control group (Group 2)
will be recruited from an existing study subject regis-
try established by the Memory Clinic at the Felix
Platter Hospital, Basel, Switzerland. Nonsurgical con-
trols are matched to surgical patients according to
age, gender and level of education.
The study is conducted with written informed consent
from all study subjects and is conducted with respect of
the most recent version of the Declaration of Helsinki
[11]. Participants are informed that participation in the
study is voluntary, and that they are free to withdraw at
any time. Recruitment and consenting of study partici-
pants by members of the research team is in-line with
Good Clinical Practice (GCP) [12].
Table 1 Incidence of POCD after noncardiac surgery
Study Population Time for postoperative test POCD rate (%)
Moller et al. [1] Patients ≥60 undergoing major
abdominal, thoracic, or
orthopedic surgery
1 week and 3 months 25.8 and 9.9%, respectively
Monk et al. [2] Patients >60 undergoing minimally
invasive, intraabdominal/thoracic,
or orthopedic surgery
1 week and 3 months 41.4 and 12.7%, respectively
Johnson et al. [3] Patients 40–60 undergoing major
abdominal or orthopedic surgery
1 week and 3 months 19.2 and 6.2%, respectively
Canet et al. [4] Patients >60 undergoing minor surgery 1 week and 3 months 6.8 and 6.6%, respectively
POCD postoperative cognitive dysfunction
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Inclusion and exclusion criteria
Study inclusion and exclusion criteria appear in Table 2.
All patients aged 65 years or older, American Society of
Anesthesiologists’ physical status I–III, who are sched-
uled from major elective surgery under general
anesthesia at the University Hospital Basel, are eligible
for study inclusion in Group 1. Further inclusion criteria
comprise a home location suitable for testing, German
as their first language, and an Instrumental Activities of
Daily Living [13] score ≥6. Participants in Group 2 are
volunteers who present equal inclusion and exclusion
criteria, without planned surgery.
Outcomes
The primary endpoint of this study is the degree of
change in hippocampal volume over time between
patients with and patients without POCD. Other specific
cerebral volumes measured are the lateral ventricles, the
total grey matter volume, and regional cortical thickness.
The secondary endpoint is the correlation between
the change in cerebral volume and the change in cog-
nitive function.
Study procedures
Study-related procedures include a baseline multimodal
assessment, intraoperative data acquisition and postopera-
tive multimodal assessments on study visits scheduled
1 week, 3 months and 1 year after surgery. Figure 1 shows
the flow diagram for the study assessments on a time line.
Anesthetic management
Anesthesia will be standardized. Intravenous propofol
and fentanyl will be used for induction of general
anesthesia, atracurium or rocuronium for neuromuscu-
lar blockade. Patients will be intubated and mechanically
ventilated with an air/oxygen mixture to maintain an
end-tidal carbon dioxide at 4.6 ± 0.6 kPa. Inhalational
sevoflurane, intravenous fentanyl or remifentanil will be
used to maintain anesthesia. Intraoperatively, the dose of
anesthetics will be controlled using depth of anesthesia
monitoring at a targeted bispectral index (BIS) of 40–60
and end-tidal sevoflurane concentration monitoring.
Data will be downloaded directly from the patient
monitor (IntelliVue™ MX800, Philips Healthcare, Zurich,
Switzerland) and the anesthesia machine (Perseus™,
Dräger, Liebefeld, Switzerland) on a personal computer
using ICM+ software (Cambridge Enterprise Ltd,
University of Cambridge, United Kingdom).
Neuropsychological assessment
The Consortium to Establish a Registry for Alzheimer’s
Disease-Neuropsychological Assessment Battery (CERAD-
NAB) [14], Trail Making Tests A and B [15], and phonemic
fluency (s-words) [16] will be performed preoperatively, at
Table 2 Study inclusion and exclusion criteria
Criterion Screening procedure
Inclusion criteria
Age ≥65 years Medical record
Home location suitable for testing Medical record
German as a first language Medical record or
recruitment telephone call
IADL score ≥6 Baseline assessment
ASA physical status I–III Baseline assessment
Major elective surgerya Medical record
Planned general anesthesiaa Baseline assessment
Exclusion criteria
Cardiac surgerya Medical record
Neurosurgery including carotid
endarterectomy, or any type of surgery
precluding postoperative testinga
Medical record
(Another) major surgery within the
study timeline
Medical record, recruitment
telephone call or baseline
interview
General anesthesia up to 3 months
prior to inclusion
Medical record
Baseline MMSE score <24 Baseline
neuropsychological
assessment






History of cerebral or cerebrovascular
pathology, head trauma,
neurodegenerative illness or epilepsy
Medical record
Chronic use of psychiatric medication Medical record or
baseline interview
Alcohol or substance abuse Medical record or
baseline interview
History of chronic pain unrelated to
the planned surgery
Medical record
Chronic medical illness known to
induce encephalopathy
Medical record
Any contraindication for MRI (e.g.,




call or baseline interview
Claustrophobia Medical record, recruitment
telephone call or baseline
interview
Incidentally diagnosed disease or
unfavorable course of disease in
participants who choose not to
be informed
Any study assessment
Lack of informed consent Recruitment telephone call
ASA American Society of Anesthesiologists, DSM-5 Diagnostic and Statistical
Manual of Mental Disorders, Fifth Edition, IADL Instrumental Activities of Daily
Living, MMSE Mini-Mental State Examination
aNot applicable for the nonsurgical control group
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7 days, 3 months and 1 year postoperatively. Training of all
study personnel and supervision of cognitive testing will be
carried out by the Memory Clinic at Felix Platter Hospital.
Cognitive functions will be quantified using the CERAD-
NAB total score [17], in its demographically-corrected form
[18]. A correction for short-term practice effects will be
carried out based on previous work [19]. Table 3 shows the
neuropsychological subtests used in this study [20]. The 15
variables resulting from neuropsychological assessment are
converted into standard scores (z-scores) based on a nor-
mative sample [21], and the z-score changes from baseline
are calculated. POCD is diagnosed if the decline is >1.0
standard scores in two or more of the 15 variables based on
the diagnostic guideline for mild cognitive impairment and
dementia related to Alzheimer’s disease by the National
Institute on Aging-Alzheimer’s Association [22] and the
American Psychiatric Association’s Diagnostic and Statis-
tical Manual of Mental Disorders (DSM-5) [23]. Postopera-
tive delirium is assessed using the Delirium Observation
Screening scale [24] and, if applicable, the Confusion
Assessment Method [25], administered 3 times daily until
the fifth postoperative day.
Other assessments
Other assessment tools include the Charlson Comorbidity
Index [26]; the Instrumental Activities of Daily Living
[13], the Geriatric Depression Scale [27], and the Short
Form Health Survey [28], and will be assessed at baseline,
Fig. 1 Flow diagram of study procedures
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at 3 months, and 1 year postoperatively. Subjective
grading of cognitive functions and subjective grading of
pain are determined on numeric rating scales at baseline,
7 days, 3 months and 1 year postoperatively. Subjective
grading of change in cognitive functions (five-point
Likert scale) and subjective grading of successful
surgery (yes/no) are assessed at 7 days, 3 months and
1 year postoperatively.
Magnetic resonance imaging
Cerebral MRI will be performed at baseline, at 3 months,
and 1 year postoperatively on the same day as the neuro-
psychological assessment. MRI analysis will be carried
out by the Division of Neuroradiology at the University
Hospital Basel. High-resolution anatomic and diffusion
cerebral MRI will be performed using the hospital’s
3-Tesla MAGNETOM Prisma™ MRI scanner (Siemens,
Zurich, Switzerland). For MRI analysis, we will assume
that the same regions as those described in mild cogni-
tive impairment and Alzheimer’s disease [29] are rele-
vant to POCD. We will perform a region of interest
(ROI) analysis (hippocampus, lateral ventricle, total grey
matter volume, regional cortical thickness). Cortical
reconstruction and volumetric segmentation will be
performed with the FreeSurfer software suite [30], which




Sample size is estimated based on data describing hippo-
campal volume. The clinically relevant difference is
defined as the difference in hippocampal volume be-
tween normal subjects (2.8 ± 0.5 cm3) and patients with
mild cognitive impairment (2.4 ± 0.4 cm3) [29]. Assum-
ing an incidence of POCD of 41% one week after surgery
in this age group [2], and a standard deviation of the
hippocampal volume change of 0.45 in both patients
with and without POCD, a total sample size of 56
subjects may detect a difference of 0.4 cm3 in hippocam-
pal volume [29] with a power of 90% at a two-sided
significance level of 5%. To compensate for the high loss
to follow-up, which is unfortunately typical for studies
on POCD [31] and estimated at 20%, we will recruit 70
patients in the surgical group (Group 1). The number of
study participants in the nonsurgical control group
(Group 2) is arbitrarily set at 30.
Statistical analysis plan
The quantitative imaging results will be correlated to the
CERAD-NAB total score performance obtained on the
same day as the MRI scans. The relationship of changes
in volume with intraoperative depth of anesthesia (BIS)
and the administered dose of sevoflurane expressed as
age-corrected minimum alveolar concentration (MAC)
equivalent [32] multiplied by time of administration will
Table 3 Subtests of the neuropsychological assessment battery used for diagnosis of POCD
Test variable Test description Domain tested
CERAD-NAB word list-encoding Total number of correctly learned words across three learning trials
(number of words per trial = 10)
Verbal episodic learning
CERAD-NAB word list-delayed free recall Total number of correctly remembered words after a delay
following encoding
Verbal episodic memory
CERAD-NAB word list-savings Proportion of correctly recalled words during delayed free recall
relative to words learned in learning trial 3
Verbal episodic memory
CERAD-NAB word list-discriminability Rate of correctly recognized words from encoding Verbal episodic memory
CERAD-NAB word list-intrusion errors Total number of intrusions committed during word list-encoding
and -delayed free recall
Executive functions
CERAD-NAB figures-copy Copy of four figures (circle, diamond, overlapping rectangles, cube) Visuospatial ability
CERAD-NAB figures-delayed recall Number of correctly reproduced figures from figures-copy
following a delay
Visual memory
CERAD-NAB figures-savings Proportion correctly reproduced figures at figures-delayed recall
relative to figures-copy
Visual memory
Semantic fluency-animals Number of animals produced within 1 min Semantic memory
Boston naming test (15-items) Number of spontaneously correctly named black and white line
drawings (maximum= 15)
Language
Trail making test A Time required to connect circles numbered from 1 to 25 in
ascending order
Psychomotor speed
Trail making test B Time required to connect circles containing numbers (1–13) and
letters (A-L) in ascending and alternating order
Executive functions
Phonemic fluency Number of words starting with the letter S produced within 1 min Executive functions
CERAD-NAB Consortium to Establish a Registry for Alzheimer’s Disease-Neuropsychological Assessment Battery. Adapted from Mistridis et al. [20]
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be calculated. We will use voxel-wise, multivariate analysis
of variance (ANOVA) and the classification/prediction
procedure on multi-parameter MRI data in order to build
optimal composite predictors of patients’ neuropsycho-
logical outcomes. All statistical analyses will be performed
using SPSS Statistics software, version 22 (IBM, Inc.,
Zurich, Switzerland). All graphs will be plotted using
Prism, version 6 (GraphPad Software, Inc., La Jolla, CA,
USA). An interim analysis will be performed to assess
quality of data after primary data acquisition from 20
participants. We will follow the Strengthening the Report-
ing of Observational studies in Epidemiology (STROBE)
statement [33] for all future reports related to this study.
Data monitoring and stopping rules
The EC agreed that monitoring would be performed by
the interdisciplinary study team. This team will evaluate
the progress of the trial, verify the accuracy and com-
pleteness of the case report forms, and ensure that all
protocol requirements and investigator’s obligations are
being fulfilled. The progress of the trial is evaluated
every 6 months. The investigators may terminate the
study prematurely according to certain circumstances
(e.g., ethical concerns, insufficient participant recruit-
ment, when the safety of the participants is doubtful or
at risk, or when alterations in accepted clinical practice
make the continuation of a clinical trial unwise).
Study safety and reporting of adverse events
There are no specific safety concerns related to this
study. During initial screening of participants in the
recruitment phase, any subject that presents potential
safety concerns related to MRI will be excluded from the
study. Above all, MRI does not use ionizing radiation,
and there are no known harmful side-effects associated
with temporary exposure to the strong magnetic field
used by MRI scanners [34]. However, if a serious adverse
event should occur, it will be reported to the EC within
the appropriate time frame.
Discussion
This observational cohort study prospectively evaluates
the relationship of cerebral grey matter volume and
POCD in elderly patients after major noncardiac surgery
under sevoflurane anesthesia. The primary hypothesis of
this investigation is that POCD is accompanied by a loss
of cerebral grey matter. Our secondary hypothesis is that
the degree of POCD correlates with the loss of grey mat-
ter in brain areas relevant for cognitive functions. There
are several potential implications of this study for future
clinical practice. The validation of reproducible anatom-
ical parameters or biomarkers, such as the specific brain
volumes examined in our cohort, will help to identify
high-risk patients and may serve to evaluate the effect of
preventive strategies and treatment interventions for
POCD in clinical follow-up studies. In summary, find-
ings of this study may contribute to improve the diagno-
sis and prevention of POCD in the future. In the
following, we discuss considerations regarding study
design, endpoints, choice of study collective, surgical
procedures and anesthetic technique.
Study design
The cohort study design chosen for our study enables
investigative research in a real-life clinical context with-
out influencing state-of-the-art medical care of patients.
No study-related intervention is planned in participating
patients, and risks are minimal. Given the lack of clinical
data and missing preventive and/or clinical treatment
approaches towards POCD, our study is aimed to inves-
tigate an association between the cognitive decline and
an anatomical biomarker. At this point, POCD research
is limited to noninterventional clinical studies, hence the
prospective observational design of this study.
Endpoints
The choice of radiological endpoints of our investigation
is based on the findings of AddNeuroMed study [29].
Liu et al. reported that the degree of atrophy in specific
cortical areas correlates with the results of neuropsycho-
logical assessment tests obtained by subjects with
various cognitive disorders (unrelated to surgery) [29].
We assume that brain areas affected in POCD are com-
parable to those concerned in Alzheimer’s disease or
mild cognitive impairment.
Methodological considerations
Choice of study collective
Although POCD was described in middle-aged patients
[3], the disorder has its highest incidence among
patients over the age of 65 years. As most research on
POCD was done in this age group, we decided to set the
cut-off for participant age at 65 years. We excluded
subjects with conditions known to induce changes in
cerebral anatomy such as Alzheimer’s disease and other
forms of dementia, a history of severe neurological dis-
ease, or chronic pain in order to obtain a patient sample
free of pre-existing cognitive disorders that might con-
found the relationship between brain volumes and
POCD. The addition of a group of nonsurgical partici-
pants serves to control for practice effects related to
neuropsychological assessment, to observe the physio-
logical cerebral atrophy rates in volunteers matched to
the surgical group, and to establish a paradigm for
further research on POCD.
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Choice of surgical procedures
We carefully considered the range of surgical procedures
to include in our study. We excluded cardiac surgery
because of potential issues with cardiopulmonary bypass,
surgery of the brain or extracranial blood vessels, and
any type of surgery of the face or neck that would
preclude patients’ active participation in the postopera-
tive neuropsychological assessments. Emergency proce-
dures were also excluded, since we would be unable to
measure the patient’s baseline. At our institution, ab-
dominal, gynecologic, urologic, vascular and orthopedic
procedures are the most commonly performed major
noncardiac surgeries in older adults. Most of these
surgeries involve a hospital stay of at least 5 days.
Although this study is monocentric, we strongly believe
that the resulting study cohort is representative of a gen-
eral surgical population.
Choice of anesthetic technique
In this study with pilot character, we chose to investigate
exclusively Sevoflurane-based general anesthesia, in
order to standardize anesthetic management as a meas-
ure to minimize bias. Sevoflurane anesthesia is delivered
by the attending anesthetist primarily based on BIS
targets (40–60) and clinical judgement. Given that the
choice of anesthetic technique only marginally influ-
ences the risk of developing POCD in surgical patients
[35], we intend to examine the effect of other anesthetic
drugs (e.g., propofol as total intravenous anesthesia) and
other anesthetic techniques (e.g., neuraxial or regional
anesthesia) on brain volumes and POCD in follow-up
studies with similar research protocols. Airway manage-
ment is standardized as all patients participating in this
study are intubated and mechanically ventilated. Other
aspects of intraoperative anesthetic management such as
the use of opioids or muscle relaxants and hemodynamic
management are left at the discretion of the attending
physician following existing institutional guidelines.
Diagnosis of POCD
POCD is a complex neuropsychological disorder present-
ing as a decline in various cognitive domains after surgery
and may at times be difficult to diagnose. Clinical
cognitive outcomes research is complicated by the fact
that there is no universal definition of POCD. Assessment
for POCD comprises a time-intensive combination of
neurocognitive function tests, and expert evaluation is
mandatory for a valid diagnosis of POCD. In the literature,
large differences in methodology (e.g., the test batteries
used, the interval between sessions, the endpoints to be
analyzed, statistical methods) and diagnostic criteria for
POCD are apparent [31]. In our study, the diagnosis of
POCD is based on a decrease of standard scores in the
CERAD-NAB.
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